Table 3

Prognostic ability of each staging system
Patients linear trend χ2 test −2 log likelihood P-value
All patients (n = 150)
GPS 53.761 588.797 <0.0001
mGPS 46.707 601.175 <0.0001
CLIP 109.309 545.36 <0.0001
JIS 64.461 570.82 <0.0001
BCLC 61.89 577.75 <0.0001
TNM 41.6 589.84 <0.0001
Curative treatment group (n = 77)
GPS 16.33 169.300 <0.0001
mGPS 5.07 177.93 0.03
CLIP 11.28 171.76 0
JIS 9.68 172.22 0
BCLC N/O N/O 0.08
TNM N/O N/O 0.09
Non-curative treatment group (n = 73)
GPS 23.71 322.27 <0.0001
mGPS 28.815 322.579 <0.0001
CLIP 29.480 311.68 <0.0001
JIS 16.72 326.370 <0.0001
BCLC 20.98 321.9 <0.0001
TNM 16.42 326.7 <0.0001

Abbreviations: GPS = Glasgow Prognostic Score; mGPS = modified Glasgow Prognostic Score;

CLIP = the Cancer of the Liver Italian Program; JIS = the Japan Integrated Staging score;

BCLC = the Barcelona Clinic Liver Cancer; TNM = tumor nodes metastasis classification; N/O = not obtained.

Kinoshita et al.

Kinoshita et al. BMC Cancer 2013 13:52   doi:10.1186/1471-2407-13-52

Open Data